Dr. Farzaneh Mohammadi, MD

Dr. Mohammadi practices at Elica Health Centers - North Highlands in North Highlands, California.

Dr. Mohammadi's NPI, 1093753410, was assigned on June 4, 2006. Dr. Mohammadi holds California license 52264.

Dr. Mohammadi's primary practice is Elica Health Centers - North Highlands, at 4815 Watt Avenue, North Highlands, CA 95660. The practice phone is (916) 454-2345.

Dr. Mohammadi's primary practice is Elica Health Centers - North Highlands in North Highlands, California. The medical group on file is Elica Health Centers. Dmand AI also links Dr. Mohammadi to 1 more home health agency and 1 medical group, each named with a free account. Dr. Mohammadi's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohammadi practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mohammadi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Mohammadi's licenses on file in 2 states: California and New York.

CMS data shows 440 Medicare services from Dr. Mohammadi across 4 procedure codes in 2024, for 197 Medicare patients. Medicare paid $35,093 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Mohammadi in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mohammadi's median patient age at 45, with 60% women.

In 2024, Dr. Mohammadi wrote 232 Medicare Part D claims for 85 patients. 83% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $404 in total drug cost. In 2021, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mohammadi for performance year 2024, reported as part of a group. Dr. Mohammadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 35 general payments to Dr. Mohammadi from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $206.